Cronos Group Inc. (NASDAQ:CRON) tinted gains of +4.67% (+0.61 points) to US$13.67. The volume of 10.37 Million shares climbed down over an trading activity of 10.88 Million shares. EPS ratio determined by looking at last 12 month figures is -0.03. Over the same time span, the stock marked US$15.3 as its best level and the lowest price reached was US$4.75. The corporation has a market cap of US$2.44 Billion.
Cronos Group Inc. (NASDAQ:CRON)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 14.63 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 3 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 1 think it is Hold. Recently, analysts have updated the overall rating to 1.6. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
NanoString Technologies, Inc. (NASDAQ:NSTG) is worth US$604.34 Million and has recently risen 4.64% to US$21.19. The latest exchange of 0.45 Million shares is below its average trading activity of 286.62 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$20.41 while the mean 12-month price target for the shares is US$17.67.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 11.97, and a price to sales ratio of 5.4. For the past 5 years, the company’s revenue has grown 38%, while the company’s earnings per share has grown 67.8%. With an institutional ownership near 92.9%, it carries an earnings per share ratio of -0.98.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 2 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.